Mediclinic is committed to maintaining strict principles of good corporate governance and the highest standards of integrity and ethics. The Board accepts full responsibility for corporate governance and is committed to ensuring a high standard of discipline, independence, ethics, equity, social responsibility, accountability, cooperation and transparency.
The Board is satisfied that the Company, as a company registered in accordance with the laws of England and Wales with a primary listing on the London Stock Exchange, meets the requirements of the UK Companies Act of 2006, the UK Listing Authority’s Listing Rules and the majority of the principles of the UK Corporate Governance Code issued by the Financial Reporting Council, most recently updated in April 2016. As the Company also has a secondary listing on the JSE Limited (“JSE”), the South African stock exchange, the Company also meets all relevant requirements of the JSE Listings Requirements. The Company’s application of the governance principles contained in the UK Corporate Governance Code, alternatively an explanation of the non-application thereof, is reported on annually in the Company’s annual report, available in the Investor Relations section of the website.
Articles of Association
The Company is further governed by its Articles of Association. A rigorous policy review of the pre-takeover policies of the Company and
Mediclinic International Limited will be conducted by the Board to ensure the continued application of the Group’s
In accordance with the UK Corporate Governance Code, the Board has established certain Board Committees which committees have defined tasks in terms of approved terms of reference.
Corporate Governance Contact Persons
Ms Victoria Dalby
Ms Léanne Heerink-Smit
Corporate Governance Reports
A Corporate Governance Report is included in the annual report. Please visit the Investor Relations section for the latest and previous reports